Business Context and Reporting Period
Company: Babcock & Wilcox Enterprises, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 8, 2022
Reporting Period: The filing reports on events occurring on August 8, 2022, specifically regarding amendments to existing credit and reimbursement agreements.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, or margin data. The financial metrics disclosed are limited to transaction costs and covenant thresholds:
- Amendment Fees Paid: $125,000 to PNC Bank and $275,000 to MSD PCOF Partners XLV, LLC (Total: $400,000).
- Permitted Dividend: Up to $3,715,000 in preferred equity dividends prior to September 30, 2022.
- Liquidity Covenant: A new requirement to maintain a current ratio (current assets to current liabilities) of not less than 1.25:1.00 as of the end of the fiscal quarter ended June 30, 2022.
Material Changes
The Company entered into two material definitive agreements on August 8, 2022:
- Amendment to Revolving Credit Agreement: Modified terms with PNC Bank to waive certain payment conditions, enabling the payment of the preferred equity dividend mentioned above.
- Amendment to Reimbursement Agreement: Modified terms with MSD PCOF Partners XLV, LLC to similarly waive payment conditions for the dividend and impose the new current ratio covenant.
Outlook, Risks, and Management Commentary
Management Commentary: The amendments were executed to facilitate a specific dividend payment while introducing stricter liquidity monitoring via the new current ratio covenant.
Risks and Contingencies:
- Covenant Compliance: The Company is now contractually obligated to maintain a minimum current ratio of 1.25:1.00. Failure to meet this threshold could constitute a default.
- Related Party Transactions: Lenders and their affiliates may continue to provide various financial services to the Company for customary fees, creating potential conflicts of interest or ongoing financial obligations.
Investor Verification Checklist
- Verify the Company's actual current ratio as of June 30, 2022, to confirm compliance with the new 1.25:1.00 covenant.
- Confirm the execution and amount of the preferred equity dividend payment prior to the September 30, 2022 deadline.
- Review the full text of the Amended Revolving Credit Agreement and Amended Reimbursement Agreement for additional covenants or restrictions not summarized in this 8-K.
- Monitor future filings for any waivers or further amendments related to the new liquidity covenant.